Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
6,624.70
(
-1.36%
)
US TECH 100
23,755.20
(
-1.56%
)
Dow Jones
46,225.15
(
-1.63%
)
Brent Oil
108.24
(
1.56%
)
Bitcoin
71,170.93
(
-0.10%
)
News Focus
News Focus

Replies to post #155920 on Biotech Values

Replies to #155920 on Biotech Values
icon url

DewDiligence

01/30/13 9:41 PM

#156159 RE: DewDiligence #155920

B-I starts Rituxan-FoB trial in second indication (NHL):

http://www.bloomberg.com/news/2013-01-30/boehringer-testing-copy-of-rituxan-in-type-of-lymphoma.html

A phase-3 trial in RA began in Sep 2012 (#msg-79555847).